CompaniesPersImmune

PersImmune

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

3

As Collaborator

1

Total Enrollment

1,037

By Phase

PHASE1: 1

By Status

UNKNOWN: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
NCT04292249
NCT02667093
NCT03072498
NCT03258359
Hover over trial bars to see details

Recent Trials

NCT03258359Lead Sponsor
Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)
PHASE1Unknown
12 participants
Started: Jan 1, 2018 · Completed: Dec 1, 2020
NCT03072498Lead Sponsor
Collection of Samples From Patients With MDS
N/AUnknown
24 participants
Started: Apr 6, 2017 · Completed: Mar 5, 2021
NCT02667093Lead Sponsor
Samples From Leukemia Patients and Their Donors to Identify Specific Antigens
N/AUnknown
50 participants
Started: Jan 31, 2013 · Completed: Dec 31, 2020
NCT04292249Collaborator
Predictive Value of suPAR and hsCRP on Postoperative Mortality in Cardiac Surgery
N/ACompleted
951 participants
Started: Aug 6, 2012 · Completed: Dec 16, 2019